EP

Ezhilarasi Perumal

Active Director Director DIN 11836882
DIN 11836882 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ezhilarasi Perumal

Ezhilarasi Perumal is a Director at Thulir Healthcare Private Limited (since 2026).

DIN 11836882
Primary Designation Director
First Appointment 18 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Thulir Healthcare Private Limited U86100TN2026PTC195550
Director18 Jul 20262026Active

Board colleagues of Ezhilarasi Perumal

NameDINCompanyDesignation
Ayyappan Vigneswary11753332Thulir Healthcare Private LimitedManaging Director
U86100tn2026ptc195550 U86100tn2026ptc195550Thulir Healthcare Private LimitedCompany/Llp

Directorship timeline

Open interactive timeline →
Thulir Healthcare Private Limited
Premium access

Shareholding and investment profile for Ezhilarasi Perumal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ezhilarasi Perumal

Ezhilarasi Perumal currently holds 1 directorship: Thulir Healthcare Private Limited (Director, since 18 Jul 2026).

Ezhilarasi Perumal was first appointed on 18 Jul 2026 as Director at Thulir Healthcare Private Limited.

The current boards of Ezhilarasi Perumal's companies include Ayyappan Vigneswary (Thulir Healthcare Private Limited), U86100tn2026ptc195550 U86100tn2026ptc195550 (Thulir Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available